Ionis Pharmaceuticals IONS Available For Sale Securities Debt Maturities Within One Year Percentage
Available For Sale Securities Debt Maturities Within One Year Percentage at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearPercentage.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's available for sale securities debt maturities within one year percentage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's available for sale securities debt maturities within one year percentage?
- Ionis Pharmaceuticals (IONS) reported available for sale securities debt maturities within one year percentage of 67% in Q1 2026.
- How has Ionis Pharmaceuticals's available for sale securities debt maturities within one year percentage changed year-over-year?
- Ionis Pharmaceuticals's available for sale securities debt maturities within one year percentage decreased by 0.0% year-over-year, from 67% to 67%.
- What does available for sale securities debt maturities within one year percentage mean?
- The portion of debt investments maturing in less than one year.
- How do you interpret available for sale securities debt maturities within one year percentage?
- A higher percentage indicates greater liquidity and lower interest rate risk, while a lower percentage suggests a longer-term investment strategy.
- How does available for sale securities debt maturities within one year percentage compare across companies?
- Used by treasury departments to manage cash flow and ensure funds are available for operational needs.